As specialty therapies grow in complexity and cost, payer utilization....
By Root Woldu For patients on specialty therapies, manufacturer copay....
Life sciences organizations face mounting competition in the specialty pharmaceutical....
As specialty therapies grow more complex and patient expectations continue....
Switching patient support hub vendors is often necessary, but without....
As patient access grows more complex, traditional patient support models....
In today’s evolving market, patient support programs (PSPs) are expected....
By Kathy Pendergrass In 2026, significant changes and policy uncertainties....
With rising complexities in patient affordability and coverage, life sciences....
The New Patient Support Program: Why Regulatory Shifts Require a....
